CYPA promotes the progression and metastasis of serous ovarian cancer (SOC) in vitro and in vivo
Abstract Ovarian cancer (OC) is a type of gynaecological malignancy with high mortality in females. Serous ovarian cancer (SOC) is a distinct subtype of OC with poor early diagnosis. Given the limitations of traditional therapies, such as chemotherapy, targeted treatment is therefore a promising the...
Main Authors: | Zhi-Ying Qi, Fang Wang, Ying-Ying Yue, Xue-Wang Guo, Rui-Meng Guo, Hong-Lin Li, Yan-Ying Xu |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-11-01
|
Series: | Journal of Ovarian Research |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13048-019-0593-2 |
Similar Items
-
Gastric metastasis of ovarian serous cystadenocarcinoma
by: Yang S
Published: (2018-09-01) -
Digital pathology-based study of cell- and tissue-level morphologic features in serous borderline ovarian tumor and high-grade serous ovarian cancer
by: Jun Jiang, et al.
Published: (2021-01-01) -
GRHL2 Upregulation Predicts a Poor Prognosis and Promotes the Resistance of Serous Ovarian Cancer to Cisplatin
by: Nie Y, et al.
Published: (2020-06-01) -
A case of synchronous serous ovarian cancer and uterine serous endometrial intraepithelial carcinoma
by: Maho Shimizu, et al.
Published: (2021-06-01) -
Discovery of Novel Small Molecule Anti-HCV Agents via the CypA Inhibitory Mechanism Using O-Acylation-Directed Lead Optimization
by: Wenzhong Yan, et al.
Published: (2015-06-01)